Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization: Upstream Bio (UPB)
Upstream Bio Inc (UPB) aims to secure a dominant position in asthma therapy through the development of verechemab. The company's historical EV/EBITDA trend reflects the current business valuation, where the current mark equals 0.00. Simultaneously, production capacities are being modernized to meet global standards. However, geopolitical instability and logistics disruptions create risks for conducting international clinical trials.
UPB (upstreambio.com): analytical breakdowns and indicator data
- market price and analyst price targets:
- company stock exchange capitalization indicators:
- book value of equity indicators:
- debt level and financial liquidity data:
Total Debt to Capital Upstream Bio Inc|UPB - Long-Term Liabilities to Capital|Short-Term Debt to Equity Ratio Upstream Bio|UPB - Company Aggregate Debts|Debt to Book Capitalization Ratio Upstream Pharma|UPB - Long-Term Liabilities|Company Short-Term Debt Upstream Bio|Quick Liquidity Indicator upstreambio.com
- net income and valuation multiples indicators:
UPB - Profit After Payment of Taxes|Expected Profit Upstream Bio Inc|UPB - Company Value to Net Income|Forward P/E Multiple Upstream Bio Inc|UPB - Price to Earnings Adjusted for Growth Rate|EV/EBITDA Multiple Upstream Pharma|UPB - Operating profit EBITDA|Earnings per share for the last twelve months Upstream Bio|UPB - Net earnings per share for the last 12 months|Year-over-year net earnings per share growth for the last 12 months upstreambio.com|UPB - Earnings per share increase in current year|Earnings growth forecast for next year Upstream Bio Inc
Fundamental company analysis:UPB (Upstream Bio Corp)
The specifics of Upstream Bio Inc. (UPB) cold chain logistics directly impact the historical EV/EBITDA multiple, reflecting asset value through the lens of operational efficiency. This indicator compares total market capitalization, including debt, against earnings before depreciation and amortization, allowing investors to assess the real value of the business and the extent to which the debt load influences invested capital.
Direct competitors
Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Argenx ARGX|BNTX - Enterprise Value to EBITDA Ratio|ABVX - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|admabiologics.com (ADMA) - Enterprise Value to EBITDA Ratio|PTGX (Protagonist) - Enterprise Value to EBITDA Ratio|Immunovant Inc (IMVT) - EV/EBITDA Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Kiniksa Pharmaceuticals Ltd|Enterprise Value to Operating Income Before Depreciation GRFS (Grifols Biemat)|EV/EBITDA Multiple ADPT|CLDX - Company Value to EBITDA|Aurinia Pharmaceuticals Inc. - Enterprise Value to EBITDA Ratio|EV/EBITDA Multiple BioCryst Pharmaceuticals, Inc. BCRX|VERA - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to Operating Income Before Depreciation Ratio DNTH|Pharvaris N.V. (PHVS) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|ABCL - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to EBITDA Ratio TRML|PGEN (Precigen Inc) - Enterprise Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Pharming (PHAR)|NKTR (Nektar Corp) - Business Value to Operating Income Before Depreciation|EV/EBITDA Multiple ZBIO (Zenas Biopharma Inc)|immunome.com (IMNM) - Company Value to EBITDA|Gossamer Bio - EV/EBITDA Multiple|KALV - EV/EBITDA Multiple|Septerna Corp (SEPN) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to EBITDA Ratio Pieris Corp|Enterprise Value to EBITDA Ratio SVRA|RIGL: Business Value to Operating Income Before Depreciation|EV/EBITDA Multiple ANAB|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization ATXS (Astria Therapeutics Inc)|EV/EBITDA Multiple ENGN (enGene Bio)|Total Company Value to Operating Income Before Depreciation Ratio rapt.com (RAPT)|JBIO - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to EBITDA aclaristx.com|KYTX (Kyverna Therapeutics, Inc.) - Enterprise Value to EBITDA Ratio|Tiziana Life Sciences Ltd. - Business Value to Operating Income Before Depreciation|CABA (Cabaletta Bio, Inc) - EV/EBITDA Multiple|Ventyx Biosciences, Inc (VTYX) - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Theratechnologies Inc. (THTX)|avalotx.com - Enterprise Value to Operating Income Before Depreciation|EV/EBITDA Multiple ELDN (Eledon Pharmaceuticals, Inc.)|AGEN - Enterprise Value to EBITDA Ratio|CLYM: Enterprise Value to EBITDA Ratio|ZURA - EV/EBITDA Multiple|aTyr Pharma, Inc. (ATYR) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to Operating Income Before Depreciation Ratio ADAG (Adagene Inc.)|IMA (ImageneBio) - EV/EBITDA Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization STTK|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Equillium, Inc. (EQ)|CNTB: Company Value to Operating Income Before Depreciation Ratio|EV/EBITDA Multiple IMUX (Immunic)|Business Value to Operating Income Before Depreciation ATRA|InflaRx GmbH - EV/EBITDA Multiple|XFOR - EV/EBITDA Multiple|adicetbio.com (ACET) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Celularity - Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization INmune Bio, Inc.|Enterprise Value to EBITDA Ratio barinthusbio.com (BRNS)|EV/EBITDA Multiple KZR|EV/EBITDA Multiple SAB Biotherapeutics Inc. (SABS)|Akari Therapeutics plc - Enterprise Value to EBITDA Ratio|Business Value to Operating Income Before Depreciation ENLV|Q32 Bio Corp - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio geovax.com GOVX|Edesa Biotech (EDSA) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to EBITDA Ratio iBio Inc|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Carisma Therapeutics Inc|Enterprise Value to EBITDA Ratio XTL Bio (XTLB)|Enterprise Value to EBITDA Ratio BOLT (Bolt Biotherapeutics)|EV/EBITDA Multiple hcwbiologics.com (HCWB)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Aptevo Therapeutics Inc. APVO|AIM: Enterprise Value to Operating Income Before Depreciation|Aditxt Corp - EV/EBITDA Multiple|Company Value to EBITDA GRI Bio Corporation|XRTX (XORTX Therapeutics Inc.) - Enterprise Value to EBITDA Ratio|reshapelifesciences.com (HIND) - EV/EBITDA Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Revelation Biosciences, Inc.|Indaptus Therapeutics Inc - Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Scinai (SCNI)|Total Company Value to Operating Income Before Depreciation Ratio calcimedica.com|Affimed N.V. - Enterprise Value to EBITDA Ratio|Enterprise Value to Operating Income Before Depreciation Ratio ALLK (Allakos Inc)|HOOK - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Business Value to Operating Income Before Depreciation IGMS (IGM Biosciences, Inc.)|ITOS: EV/EBITDA Multiple|Company Value to EBITDA Ocean Biomedical Corp (OCEA)|TCBP (TC Biopharm) - EV/EBITDA Multiple|EV/EBITDA Multiple thirdharmonicbio.com
